Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Recent evidence suggests that there is a link between metabolic diseases and bacterial populations in the gut. The aim of this study was to assess the differences between the composition of the intestinal microbiota in humans with type 2 diabetes and non-diabetic persons as control. METHODS AND FINDINGS: The study included 36 male adults with a broad range of age and body-mass indices (BMIs), among which 18 subjects were diagnosed with diabetes type 2. The fecal bacterial composition was investigated by real-time quantitative PCR (qPCR) and in a subgroup of subjects (N = 20) by tag-encoded amplicon pyrosequencing of the V4 region of the 16S rRNA gene. The proportions of phylum Firmicutes and class Clostridia were significantly reduced in the diabetic group compared to the control group (P = 0.03). Furthermore, the ratios of Bacteroidetes to Firmicutes as well as the ratios of Bacteroides-Prevotella group to C. coccoides-E. rectale group correlated positively and significantly with plasma glucose concentration (P = 0.04) but not with BMIs. Similarly, class Betaproteobacteria was highly enriched in diabetic compared to non-diabetic persons (P = 0.02) and positively correlated with plasma glucose (P = 0.04). CONCLUSIONS: The results of this study indicate that type 2 diabetes in humans is associated with compositional changes in intestinal microbiota. The level of glucose tolerance should be considered when linking microbiota with metabolic diseases such as obesity and developing strategies to control metabolic diseases by modifying the gut microbiota.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Compelling evidence have shown that the composition of the gut microbiota is altered in animal models of obesity and subjects with prediabetes or type 2 diabetes compared with controls (182–186).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [183]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Chronic autoimmune inflammatory diseases, including celiac disease,17 type 2 diabetes18 and obesity19 are associated with intestinal dysbiosis.”
From Probiotics and the gut microbiota in intestinal health and disease (2010) · cites this paper as [18]
In the citing paper
“Conversely, heterocyclic amines and glycan derived from red meat may promote inflammation in gut health due to higher concentration of Bacteroides and Fusobacterium and lower levels of Lactobacillus and Roseburia, which are also linked with lower anti-inflammatory responses and increased incidence of type 2 diabetes [191,192,193].”
From Impact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective (2020) · cites this paper as [191]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
[RETRACTION]Translational research into gut microbiota: new horizons in obesity treatment
Tsukumo, D. M., Carvalho, B. M., Carvalho-Filho, M. A., & Saad, M. J. A. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000200004 · Cited by 44
RetractedTranslational research into gut microbiota: new horizons in obesity treatment
Tsukumo, D. M. L., Carvalho, B. M., Filho, C., & Saad, M. J. A. (2013) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302013000900014 · Cited by 17
RetractedAn obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 1×
“The differences in microbial composition were explained by an increased capacity of the obesity-associated microbiome to harvest energy from the diet [13].”
BackgroundA core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176
The Ribosomal Database Project: improved alignments and new tools for rRNA analysis
Cole, J. R., Wang, Q., Cardenas, E., Fish, J., Chai, B., Farris, R. J., Kulam-Syed-Mohideen, A. S., McGarrell, D. M., Marsh, T., Garrity, G. M., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn879 · Cited by 4,762
Inflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143
Cani, P. D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., Geurts, L., Naslain, D., Neyrinck, A., Lambert, D. M., et al. (2009) · Gut · doi:10.1136/gut.2008.165886 · Cited by 2,518 · cited 2×
“For example, levels of Bifidobacterium significantly and positively correlated with improved glucose-tolerance and low-grade inflammation in prebiotic treated-mice [1,6].”
BackgroundMicrobiota and SCFA in lean and overweight healthy subjects
Schwiertz, A., Taras, D., Schäfer, K., Beijer, S., Bos, N. A., Donus, C., & Hardt, P. D. (2010) · Obesity · doi:10.1038/oby.2009.167 · Cited by 2,457
Cited by
Items 401–500 of 1,020
Immune System: An Emerging Player in Mediating Effects of Endocrine Disruptors on Metabolic Health
Bansal, A., Henao-Mejia, J., & Simmons, R. A. (2018) · Endocrinology · doi:10.1210/en.2017-00882 · Cited by 152
“therefore, perturbations in the gut microbiome have been associated with obesity (87, 92) and diabetes (93).”
BackgroundMiura, K., Seki, E., Ohnishi, H., & Brenner, D. A. (2010) · Gastroenterology Research and Practice · doi:10.1155/2010/362847 · Cited by 149
“In human, the composition of gut microbiota differs between individuals with and without diabetes mellitus [17, 18].”
Shankar, V., Gouda, M., Moncivaiz, J., Gordon, A., Reo, N. V., Hussein, L., & Paliy, O. (2017) · mSystems · doi:10.1128/msystems.00169-16 · Cited by 145
“Alterations of the gut microbial populations have been associated with the development of metabolic disorders such as obesity and type 2 diabetes (21, 22), and gut microbiota changes during childhood can have lifelong effects (23, 24).”
BackgroundSchizophrenia and the gut–brain axis
Nemani, K., Hosseini Ghomi, R., McCormick, B., & Fan, X. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.08.018 · Cited by 151
Gut microbiota and nonalcoholic fatty liver disease
Machado, M. V., & Cortez-Pinto, H. (2012) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31457-7 · Cited by 154
Meroni, M., Longo, M., & Dongiovanni, P. (2019) · Nutrients · doi:10.3390/nu11112642 · Cited by 140
“NAFLD is broadly spread in Western countries, affecting between 20% and 40% of the adult population, possibly due to the epidemics of obesity and type 2 diabetes mellitus (T2DM) [3].”
BackgroundLee, C. B., Chae, S. U., Jo, S. J., Jerng, U. M., & Bae, S. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073566 · Cited by 165
“[30] Danish T2DM patients (n = 18) versus Healthy subjects (n = 18) α-diversity (Chao 1): – Phylum: Bacteroidetes ↑, Firmicutes ↓, Proteobacteria ↑ Class: Bacilli ↑, Bacteroidetes ↑, Betaproteobacteria ↑, Clostridia ↓ Genus: Akkermansia ↑, Alistipes ↑, Bacteroides ↓, Bifidobacterium ↓, Bilophila ↑, Catenibacterium ↓,…”
BackgroundResultInfluentialThe human microbiome and bile acid metabolism: Dysbiosis, dysmetabolism, disease and intervention
Jones, M. L., Martoni, C. J., Ganopolsky, J. G., Labbé, A., & Prakash, S. (2014) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2014.880420 · Cited by 150
“coccoides--Eubacterium rectale may be correlated with plasma glucose concentration [60].”
BackgroundPolyphenols and type 2 diabetes: A prospective review
Anhê, F. F., Desjardins, Y., Pilon, G., Dudonné, S., Genovese, M. I., Lajolo, F. M., & Marette, A. (2013) · PharmaNutrition · doi:10.1016/j.phanu.2013.07.004 · Cited by 178
Santiago-Rodríguez, T. M., & Hollister, E. B. (2019) · Viruses · doi:10.3390/v11070656 · Cited by 160
“Significant reductions in Firmicutes and the order Clostridia have been observed in subjects with T2D [107].”
BackgroundInfluentialShort-chain fatty acids and insulin sensitivity: a systematic review and meta-analysis
Pham, N. H. T., Joglekar, M. V., Wong, W. K. M., Nassif, N. T., Simpson, A. M., & Hardikar, A. A. (2023) · Nutrition Reviews · doi:10.1093/nutrit/nuad042 · Cited by 164
The association of type II diabetes with gut microbiota composition
Navab-Moghadam, F., Sedighi, M., Khamseh, M. E., Alaei-Shahmiri, F., Talebi, M., Razavi, S., & Amirmozafari, N. (2017) · Microbial Pathogenesis · doi:10.1016/j.micpath.2017.07.034 · Cited by 144
Cayres, L. C. D. F., de Salis, L. V. V., Rodrigues, G. S. P., Lengert, A. V. H., Biondi, A. P. C., Sargentini, L. D. B., Brisotti, J. L., Gomes, E., & de Oliveira, G. L. V. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.579140 · Cited by 175
“The primers were described previously and designed by using the 16S rRNA gene sequences from the Ribosomal Database Project (25).”
MethodRoles and Mechanisms of Gut Microbiota in Patients With Alzheimer’s Disease
Wu, S., Liu, X., Jiang, R., Yan, X., & Ling, Z. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.650047 · Cited by 143
Gut microbiome and nonalcoholic fatty liver diseases
Zhu, L., Baker, R. D., & Baker, S. S. (2014) · Pediatric Research · doi:10.1038/pr.2014.157 · Cited by 158
Ghosh, S., Dai, C., Brown, K., Rajendiran, E., Makarenko, S., Baker, J., Ma, C., Halder, S., Montero, M., Ionescu, V. A., et al. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00509.2010 · Cited by 147
“In recent years, dysbiosis or altered bacterial communities within intestinal microflora have been implicated in a wide range of inflammatory diseases such as inflammatory bowel disease (IBD; 31), obesity (6), diabetes (23), celiac disease (7), and colonic neoplasia (47).”
Can We Prevent Obesity-Related Metabolic Diseases by Dietary Modulation of the Gut Microbiota?
Brahe, L. K., Astrup, A., & Larsen, L. H. (2016) · Advances in Nutrition · doi:10.3945/an.115.010587 · Cited by 145
“Larsen et al. 2010 (114) Danish adults with T2D (n = 18) and healthy controls (n = 18); pyrosequencing Firmicutes including Clostrida reduced in T2D.”
BackgroundUnravelling the involvement of gut microbiota in type 2 diabetes mellitus
Arora, A., Behl, T., Sehgal, A., Singh, S., Sharma, N., Bhatia, S., Sobarzo‐Sánchez, E., & BUNGAU, S. G. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119311 · Cited by 159
Impact of Kefir Derived Lactobacillus kefiri on the Mucosal Immune Response and Gut Microbiota
Carasi, P., Racedo, S. M., Jacquot, C., Romanin, D. E., Serradell, M. A., & Urdaci, M. C. (2015) · Journal of Immunology Research · doi:10.1155/2015/361604 · Cited by 145
“Prevotella group CACCAAGGCGACGATCA GGATAACGCCYGGACCT [69]”
Longo, A. V., Savage, A. E., Hewson, I., & Zamudio, K. R. (2015) · Royal Society Open Science · doi:10.1098/rsos.140377 · Cited by 159
“Dysbiosis has been linked to chronic diseases in humans [5,6], but remains largely overlooked in the case of infectious diseases threatening wildlife [7].”
BackgroundYu, G., Gail, M. H., Shi, J., Klepac-Ceraj, V., Paster, B. J., Dye, B. A., Wang, G.-Q., Wei, W.-Q., Fan, J.-H., Qiao, Y.-L., et al. (2014) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0855 · Cited by 146
“Decreased microbial richness has been shown to be associated with disease states such as obesity, diabetes, inflammatory bowel disease, and others (3, 4, 6).”
BackgroundLi, T., Long, M., Ji, C., Shen, Z., Gatesoupe, F.-J., Zhang, X., Zhang, Q., Zhang, L., Zhao, Y., Liu, X., et al. (2016) · Scientific Reports · doi:10.1038/srep30606 · Cited by 156
The gut microbiome of horses: current research on equine enteral microbiota and future perspectives
Kauter, A., Epping, L., Semmler, T., Antão, E.-M., Kannapin, D., Stoeckle, S. D., Gehlen, H., Lübke‐Becker, A., Günther, S., Wieler, L. H., et al. (2019) · Animal Microbiome · doi:10.1186/s42523-019-0013-3 · Cited by 178
Shah, B. R., Li, B., Sabbah, H. A., Xu, W., & Mráz, J. (2020) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2020.06.010 · Cited by 158
“, 2008) and Neolithic settlements (Larsen et al., 2010).”
BELLIKCI-KOYU, E., SARER-YUREKLI, B. P., AKYON, Y., AYDIN-KOSE, F., KARAGOZLU, C., OZGEN, A. G., BRINKMANN, A., NITSCHE, A., ERGUNAY, K., YILMAZ, E., et al. (2019) · Nutrients · doi:10.3390/nu11092089 · Cited by 144
“showed a lower abundance of Firmicutes and Clostridia, and a higher abundance of Bacteroidetes and Betaproteobacteria in diabetic patients compared to the non–diabetics [67].”
ResultVariable responses of human and non-human primate gut microbiomes to a Western diet
Amato, K. R., Yeoman, C. J., Cerda, G., A. Schmitt, C., Cramer, J. D., Miller, M. E. B., Gomez, A., R. Turner, T., Wilson, B. A., Stumpf, R. M., et al. (2015) · Microbiome · doi:10.1186/s40168-015-0120-7 · Cited by 143
“Gut microbes appear to be implicated in many of these conditions [8–10], indicating a link between the human gut microbiota, diet, and physiology.”
BackgroundLiu, T., Chen, X., Xu, Y., Wu, W., Tang, W., Chen, Z., Ji, G., Peng, J., Jiang, Q., Xiao, J., et al. (2019) · Environment International · doi:10.1016/j.envint.2019.05.076 · Cited by 150
Effects of short‐term endurance exercise on gut microbiota in elderly men
Taniguchi, H., Tanisawa, K., Sun, X., Kubo, T., Hoshino, Y., Hosokawa, M., Takeyama, H., & Higuchi, M. (2018) · Physiological Reports · doi:10.14814/phy2.13935 · Cited by 137
“Specific features of the gut microbiome, including bacterial species composition and diversity, may be associated with metabolic disorders, such as obesity (Turnbaugh et al. 2009; Le Chatelier et al. 2013) and type 2 diabetes (Larsen et al. 2010; Qin et al. 2012).”
BackgroundFecal Microbiota Transplantation
Borody, T. J., & Campbell, J. (2012) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2012.08.008 · Cited by 115
Gut microbiome, prebiotics, intestinal permeability and diabetes complications
Snelson, M., de Pasquale, C., Ekinci, E. I., & Coughlan, M. T. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101507 · Cited by 154
Masoud, W., Vogensen, F. K., Lillevang, S., Abu Al-Soud, W., Sørensen, S. J., & Jakobsen, M. (2012) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2011.11.014 · Cited by 142
Self-citationModulating gut microbiota as an anti-diabetic mechanism of berberine
Han, J., Lin, H., & Huang, W. (2011) · Medical Science Monitor · doi:10.12659/msm.881842 · Cited by 140
“Researchers found that the proportions of Firmicutes and Clostridia were significantly reduced, while the relative abundance of Bacteroidetes and Betaproteobacteria was increased in the diabetic group compared to the control group [17].”
ResultZhou, Y.-L., He, G., Jin, T., Chen, Y., Dai, F., Luo, L., & Lin, S. (2020) · Aquaculture · doi:10.1016/j.aquaculture.2020.736261 · Cited by 155
Exploring the gut microbiota: lifestyle choices, disease associations, and personal genomics
Matute, S. P., & Iyavoo, S. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1225120 · Cited by 155
Bacteriocin production: A relatively unharnessed probiotic trait?
Hegarty, J. W., Guinane, C. M., Ross, R. P., Hill, C., & Cotter, P. D. (2016) · F1000Research · doi:10.12688/f1000research.9615.1 · Cited by 141
Microbiota and epigenetic regulation of inflammatory mediators in type 2 diabetes and obesity
Remely, M., Aumueller, E., Jahn, D., Hippe, B., Brath, H., & Haslberger, A. G. (2014) · Beneficial Microbes · doi:10.3920/bm2013.006 · Cited by 135
“, 2010), especially plasma LPS (Cani and Delzenne, 2009b; Cani et al., 2008b; Diamant et al., 2011; Larsen et al., 2010; Luoto et al., 2010; Tsukumo et al., 2009).”
BackgroundGastrointestinal changes after bariatric surgery
Quercia, I., Dutia, R., Kotler, D. P., Belsley, S., & Laferrère, B. (2014) · Diabetes & Metabolism · doi:10.1016/j.diabet.2013.11.003 · Cited by 139
“Evidence from rats and humans shows that gut microflora are different in lean versus obese subjects [92,93], and individuals with diabetes have reduced proportions of Firmicutes and Clostridia [94].”
BackgroundMost, J., Penders, J., Lucchesi, M., Goossens, G. H., & Blaak, E. E. (2017) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2017.89 · Cited by 146
The Perinatal Microbiome and Pregnancy: Moving Beyond the Vaginal Microbiome
Prince, A., Chu, D. M., Seferovic, M., Antony, K. M., Ma, J., & Aagaard, K. M. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a023051 · Cited by 155
“…al. 2005; Gophna et al. 2006; Manichanh et al. 2006; Turnbaugh et al. 2006, 2008, 2009; Bäckhed et al. 2007; Cani et al. 2007; Willing et al. 2009; Larsen et al. 2010; Schwiertz et al. 2010; Wu et al. 2010; Joossens et al. 2011; Lepage et al. 2011; Marchesi et al. 2011; Sobhani et al. 2011; Qin…”
Clinical Consequences of Diet-Induced Dysbiosis
Chan, Y. K., Estaki, M., & Gibson, D. L. (2013) · Annals of Nutrition and Metabolism · doi:10.1159/000354902 · Cited by 130
Hulston, C. J., Churnside, A. A., & Venables, M. C. (2015) · British Journal of Nutrition · doi:10.1017/s0007114514004097 · Cited by 133
“A clear association has been demonstrated between metabolic disease and compositional changes in the gut microbiota, with a lower abundance of Firmicutes and a higher proportion of Bacteroidetes and Proteobacteria in type 2 diabetic patients when compared with non-diabetic controls((8)).”
Mucosal Interactions between Genetics, Diet, and Microbiome in Inflammatory Bowel Disease
Basson, A., Trotter, A., Rodriguez-Palacios, A., & Cominelli, F. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00290 · Cited by 135
Human and rat gut microbiome composition is maintained following sleep restriction
Zhang, S. L., Bai, L., Goel, N., Bailey, A., Jang, C. J., Bushman, F. D., Meerlo, P., Dinges, D. F., & Sehgal, A. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620673114 · Cited by 139
“An unhealthy shift in the gut microbiome, known as dysbiosis, is associated with diabetes, metabolic syndrome, and fat storage (9, 10).”
BackgroundTargeting gut microbiota as a possible therapy for diabetes
He, C., Shan, Y., & Song, W. (2015) · Nutrition Research · doi:10.1016/j.nutres.2015.03.002 · Cited by 146
“[12] Larsen N, Vogensen FK, van den Berg FW, Nielsen DS, Andreasen AS, Pedersen BK, et al.”
BackgroundInfluentialModulation of Gut Microbiota in the Management of Metabolic Disorders: The Prospects and Challenges
Erejuwa, O., Sulaiman, S., & Wahab, M. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15034158 · Cited by 136
“Similar compositional changes in intestinal microbiota have also been documented in type 2 diabetic patients [32,33].”
BackgroundDuarte, S. M. B., Stefano, J. T., Miele, L., Ponziani, F. R., de Souza-Basqueira, M., Okada, L. S. R. R., Costa, F., Toda, K., Mazo, D. F. D. C., Sabino, É. C., et al. (2017) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2017.10.014 · Cited by 143
Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease
Suk, K. T., & Kim, D. J. (2019) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2019.1569513 · Cited by 149
“obesity [14], metabolic syndrome [15], diabetes [16], cardiovas-”
BackgroundTsiaoussis, J., Antoniou, M. N., Koliarakis, I., Mesnage, R., Vardavas, C. I., Izotov, B. N., Psaroulaki, A., & Tsatsakis, A. M. (2019) · Toxicology Letters · doi:10.1016/j.toxlet.2019.04.014 · Cited by 145
Soy and Gut Microbiota: Interaction and Implication for Human Health
Huang, H., Krishnan, H. B., Pham, Q., Yu, L. L., & Wang, T. T. Y. (2016) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.6b03725 · Cited by 138
Metformin and gut microbiota: their interactions and their impact on diabetes
Vallianou, N. G., Stratigou, T., & Tsagarakis, S. (2019) · Hormones · doi:10.1007/s42000-019-00093-w · Cited by 138
Dysbiotic bacteria translocate in progressive SIV infection
Klase, Z. A., Ortiz, A. M., Deléage, C., Mudd, J. C., Quiñones, M., Schwartzman, E., Klatt, N. R., Canary, L., Estes, J. D., & Brenchley, J. M. (2015) · Mucosal Immunology · doi:10.1038/mi.2014.128 · Cited by 143
Dolatkhah, N., Hajifaraji, M., Abbasalizadeh, F., Aghamohammadzadeh, N., Mehrabi, Y., & Mesgari Abbasi, M. (2015) · Journal of Health, Population and Nutrition · doi:10.1186/s41043-015-0034-9 · Cited by 132
“For instance, it has been shown that the ratio of Bacteroidetes to Firmicutes species is associated with diabetes type 2 and FBS, especially that the changes in gut microbiome are different from what is observed during obesity and a larger number of opportunistic pathogens along with a lower number of butyrate-produci…”
BackgroundObesity and the Gut Microbiota
Flint, H. J. (2011) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31821f44c4 · Cited by 134
“The ratio of Firmicutes/Bacteroidetes has also been reported to be lower in individuals with type 2 diabetes than in nondiabetic controls, and was correlated with plasma glucose concentration.(33) Given the increased incidence of type 2 diabetes among obese people, this factor needs to be taken into account in studies…”
BackgroundAlterations of the Gut Microbiota in Patients with Diabetic Nephropathy
Zhang, L., Wang, Z., Zhang, X., Zhao, L., Chu, J., Li, H., Sun, W., Yang, C., Wang, H., Dai, W., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00324-22 · Cited by 161
Espino-González, E., Dalbram, E., Mounier, R., Gondin, J., Farup, J., Jessen, N., & Treebak, J. T. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.02.014 · Cited by 154
Pedersen, R., Ingerslev, H.-C., Sturek, M., Alloosh, M., Cirera, S., Christoffersen, B. Ø., Moesgaard, S. G., Larsen, N., & Boye, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056612 · Cited by 129
“These results are however in agreement with the findings in diabetic mice and humans [7,36].”
InfluentialSelf-citationJafarnejad, S., Saremi, S., Jafarnejad, F., & Arab, A. (2016) · Journal of Nutrition and Metabolism · doi:10.1155/2016/5190846 · Cited by 132
Esteve, E., Ricart, W., & Fernández-Real, J.-M. (2011) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e328348c06d · Cited by 133
The gut microbiome in cardio-metabolic health
Hansen, T. H., Gøbel, R. J., Hansen, T., & Pedersen, O. (2015) · Genome Medicine · doi:10.1186/s13073-015-0157-z · Cited by 122
“Type 2 diabetes It has been reported that patients with T2D have a different taxonomic composition and functional potential of their gut microbiome from that of non-diabetic individuals [12-17].”
BackgroundInfluentialGut Microbiome in Obesity, Metabolic Syndrome, and Diabetes
Chen, X., & Devaraj, S. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1104-3 · Cited by 136
Gut Microbiota as an Objective Measurement for Auxiliary Diagnosis of Insomnia Disorder
Liu, B., Lin, W., Chen, S., Xiang, T., Yang, Y., Yin, Y., Xu, G., Liu, Z., Liu, L., Pan, J., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01770 · Cited by 141
Zhu, Y., Dong, L., Huang, L., Shi, Z., Dong, J., Yao, Y., & Shen, R. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.103939 · Cited by 132
Fugmann, M., Breier, M., Rottenkolber, M., Banning, F., Ferrari, U., Sacco, V., Grallert, H., Parhofer, K. G., Seissler, J., Clavel, T., et al. (2015) · Scientific Reports · doi:10.1038/srep13212 · Cited by 131
“gamma-glutamyl transferase (U/l) 18 [13–22] 13 [11–16] 0.”
Probiotics for the treatment of depressive symptoms: An anti-inflammatory mechanism?
Park, C., Brietzke, E., Rosenblat, J. D., Musial, N., Zuckerman, H., Ragguett, R.-M., Pan, Z., Rong, C., Fus, D., & McIntyre, R. S. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.07.006 · Cited by 123
The Role of the Gut Microbiome in Liver Cirrhosis Treatment
Lee, N. Y., & Suk, K. T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010199 · Cited by 138
“Dysbiosis of the gut is related with various human diseases such as obesity [40], metabolic disease [41], diabetes mellitus [42], vascular disease [43], chronic liver disease [44,45] and neuroinflammatory disease [46].”
BackgroundMetagenome and metabolism: the tissue microbiota hypothesis
Burcelin, R., Serino, M., Chabo, C., Garidou, L., Pomié, C., Courtney, M., Amar, J., & Bouloumié, A. (2013) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12157 · Cited by 124
“Besides hyperglycemia [45,46], insulin resistance in humans was also associated with changes in gut microbiota even in patients with similar body weight [47] and ectopic fat deposition [48].”
BackgroundArachidonic acid in health and disease with focus on hypertension and diabetes mellitus: A review
Das, U. N. (2018) · Journal of Advanced Research · doi:10.1016/j.jare.2018.01.002 · Cited by 138
Modulating the Microbiota as a Therapeutic Intervention for Type 2 Diabetes
Huda, M. N., Kim, M., & Bennett, B. J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.632335 · Cited by 142
“For example, one study comparing significant differences in gut microbiota diversity between T2D patients and healthy individuals was conducted on fecal samples from 18 men (24).”
BackgroundProbiotic Therapy as a Novel Approach for Allergic Disease
Toh, Z. Q., Anzela, A., Tang, M. L. K., & Licciardi, P. V. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00171 · Cited by 130
“These data highlight the important role of microbiota in immune development and the potential for immune dysregulation such as allergy and autoimmunity when there is intestinal dysbiosis (Sjogren et al., 2009; Larsen et al., 2010; Vijay-Kumar et al., 2010; Bisgaard et al., 2011).”
BackgroundAmyot, J., Semache, M., Ferdaoussi, M., Fontés, G., & Poitout, V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036200 · Cited by 127
“. Accordingly, subjects with T2D present an altered microbiota reported to be enriched in gram-negative bacteria”
BackgroundBhute, S. S., Suryavanshi, M. V., Joshi, S. M., Yajnik, C. S., Shouche, Y. S., & Ghaskadbi, S. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00214 · Cited by 134
“We also found that Known-DMs were enriched with genus Lactobacillus consistent with previous studies on diabetic subjects in different populations of the world (Larsen et al., 2010; Lê et al., 2012).”
ResultInfluentialEndocrine Disruptors in Food: Impact on Gut Microbiota and Metabolic Diseases
Gálvez-Ontiveros, Y., Páez, S., Monteagudo, C., & Rivas, A. (2020) · Nutrients · doi:10.3390/nu12041158 · Cited by 140
“Larsen et al. (2010) [23] showed that the Firmicutes phylum and Clostridia class decreased significantly in humans with T2D compared to in the healthy control group.”
BackgroundFerguson, J. F., Allayee, H., Gerszten, R. E., Ideraabdullah, F., Kris-Etherton, P. M., Ordovás, J. M., Rimm, E. B., Wang, T. J., & Bennett, B. J. (2016) · Circulation: Cardiovascular Genetics · doi:10.1161/hcg.0000000000000030 · Cited by 123
Farnesoid X Receptor Signaling Shapes the Gut Microbiota and Controls Hepatic Lipid Metabolism
Zhang, L., Xie, C., Nichols, R. G., Chan, S. H. J., Jiang, C., Hao, R., Smith, P. B., Cai, J., Simons, M. N., Hatzakis, E., et al. (2016) · mSystems · doi:10.1128/msystems.00070-16 · Cited by 126
“Here significant depletion of the class Clostridia, family Lactobacillaceae and genus Lactobacillus was observed in HFD-fed mice after Gly-MCA treatment, which is consistent with previous studies showing that Lactobacillus populations are elevated in obese mice and decrease after gastric bypass surgery (31, 32).”
ResultAssociation between blood microbiome and type 2 diabetes mellitus: A nested case‐control study
Qiu, J., Zhou, H. J., Yang, J., & Dong, C. (2019) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.22842 · Cited by 135
Gut microbiota and old age: Modulating factors and interventions for healthy longevity
Coman, V., & Vodnar, D. C. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111095 · Cited by 118
“Additionally, some human studies have also shown a correlation with diabetes (Larsen et al., 2010; Murri et al., 2013), carbohydrate con-”
Effect of Lactobacillus salivarius Ls-33 on fecal microbiota in obese adolescents
Larsen, N., Vogensen, F. K., Gøbel, R. J., Michaelsen, K. F., Forssten, S. D., Lahtinen, S. J., & Jakobsen, M. (2013) · Clinical Nutrition · doi:10.1016/j.clnu.2013.02.007 · Cited by 127
Self-citationGrams, J. M., & Garvey, W. T. (2015) · Current Obesity Reports · doi:10.1007/s13679-015-0155-x · Cited by 146
Gut Microbiota in Health and Disease
Yamashiro, Y. (2017) · Annals of Nutrition and Metabolism · doi:10.1159/000481627 · Cited by 144
Non-Nutritive Sweeteners and Their Implications on the Development of Metabolic Syndrome
Liauchonak, I., Qorri, B., Dawoud, F., Riat, Y., & Szewczuk, M. R. (2019) · Nutrients · doi:10.3390/nu11030644 · Cited by 145
“In particular, it has been reported that T2DM is associated with alterations in microbiota composition [58].”
BackgroundMomozawa, Y., Deffontaine, V., Louis, E., & Medrano, J. F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016952 · Cited by 123
“was found to be significantly reduced in diabetics”
BackgroundInfluence of Panax ginseng on obesity and gut microbiota in obese middle-aged Korean women
Song, M., Kim, B. S., & Kim, H. (2014) · Journal of Ginseng Research · doi:10.1016/j.jgr.2013.12.004 · Cited by 133
Tuohy, K. M., Fava, F., & Viola, R. (2014) · Proceedings of the Nutrition Society · doi:10.1017/s0029665113003911 · Cited by 125
Incorporating the gut microbiota into models of human and non‐human primate ecology and evolution
Amato, K. R. (2016) · American Journal of Physical Anthropology · doi:10.1002/ajpa.22908 · Cited by 135
“…microbiota have been associated with obesity, diabetes, heart disease, autoimmune disease, autism, depression, and anxiety (Turnbaugh et al., 2006; Larsen et al., 2010; Ley, 2010; Okada et al., 2010; Giongo et al., 2011; Koeth et al., 2013; Foster and McVey Neufeld, 2013; KrajmalnikBrown et al.,…”
New approaches to antimicrobial discovery
Lewis, K. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.11.002 · Cited by 143
Microbiome and diabetes: Where are we now?
Vallianou, N. G., Stratigou, T., & Tsagarakis, S. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.10.008 · Cited by 138
Molecular details of a starch utilization pathway in the human gut symbiont Eubacterium rectale
Cockburn, D. W., Orlovsky, N. I., Foley, M. H., Kwiatkowski, K. J., Bahr, C. M., Maynard, M., Demeler, B., & Koropatkin, N. M. (2015) · Molecular Microbiology · doi:10.1111/mmi.12859 · Cited by 115
“, 2013) and diabetes (Larsen et al., 2010; Qin et al., 2012; Karlsson et al., 2013; Peng et al., 2014), suggesting the importance of these organisms in maintaining optimal health.”
Backgroundvan Zanten, G. C., Knudsen, A. S., Röytiö, H., Forssten, S. D., Lawther, M., Blennow, A., Lahtinen, S. J., Jakobsen, M., Svensson, B., & Jespersen, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047212 · Cited by 136
“Ratios are reported to be altered in obese [31,32] and type 2 diabetics [33].”
InfluentialSelf-citationFrost, F., Storck, L. J., Kacprowski, T., Gärtner, S., Rühlemann, M., Bang, C., Franke, A., Völker, U., Aghdassi, A. A., Steveling, A., et al. (2019) · PLOS ONE · doi:10.1371/journal.pone.0219489 · Cited by 121
Grosicki, G. J., Riemann, B. L., Flatt, A. A., Valentino, T. R., & Lustgarten, M. S. (2020) · Sleep Medicine · doi:10.1016/j.sleep.2020.04.013 · Cited by 139
“Furthermore, increased abundance of Prevotella is associated with insulin resistance [40] and obesity [41] in human subjects, which may be a result of Prevotella-mediated biosynthesis of branch chain amino acids [42, 43].”
BackgroundOuyang, J., Lin, J., Isnard, S., Fombuena, B., Peng, X., Marette, A., Routy, B., Messaoudene, M., Chen, Y., & Routy, J.-P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00645 · Cited by 124
Effects of probiotic yogurt consumption on inflammatory biomarkers in patients with type 2 diabetes
Mohammad-Shahi, M., Veissi, M., Haidari, F., Shahbazian, H. B., Kaydani, G. A., & Mohammadi, F. (2014) · PubMed · doi:10.5681/bi.2014.007 · Cited by 118
Gryp, T., Huys, G. R. B., Joossens, M., Biesen, W. V., Glorieux, G., & Vaneechoutte, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21061986 · Cited by 133
Causal effects of gut microbiota on diabetic retinopathy: A Mendelian randomization study
Liu, K., Zou, J., Fan, H., Hu, H., & You, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.930318 · Cited by 147
“(29) discovered a significantly lower proportion of phylum Firmicutes from the fecal bacteria of 18 diabetic patients”
BackgroundGut microbiome of an 11th Century A.D. pre-Columbian Andean mummy
Santiago-Rodriguez, T. M., Fornaciari, G., Luciani, S., Dowd, S. E., Toranzos, G. A., Marota, I., & Cano, R. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138135 · Cited by 123
“The gut microbiome has been more extensively characterized compared to other human surfaces, and has been associated with several health conditions including obesity [1], colitis [2], autism [3], autoimmune diseases [4], cancer [5], diabetes [6] and inflammatory bowel disease [7].”
BackgroundFrankenfeld, C. L., Sikaroodi, M., Lamb, E., Shoemaker, S., & Gillevet, P. M. (2015) · Annals of Epidemiology · doi:10.1016/j.annepidem.2015.06.083 · Cited by 123
Crespo-Salgado, J., Vehaskari, V. M., Stewart, T., Ferris, M. J., Zhang, Q., Wang, G., Blanchard, E., Taylor, C. M., Kallash, M., Greenbaum, L. A., et al. (2016) · Microbiome · doi:10.1186/s40168-016-0195-9 · Cited by 131
“The same pattern of gut dysbiosis was reported in patients with type-2 diabetes [32].”
BackgroundPedersen, C., Gallagher, E., Horton, F., Ellis, R. J., Ijaz, U. Z., Wu, H., Jaiyeola, E., Diribe, O., Duparc, T., Cani, P. D., et al. (2016) · British Journal of Nutrition · doi:10.1017/s0007114516004086 · Cited by 117
“Larsen et al.((7)) found that Betapro-”
Liu, H., Zhang, M., Ma, Q., Tian, B., Nie, C., Chen, Z., & Li, J. (2020) · Food & Function · doi:10.1039/d0fo00855a · Cited by 136
Focus on the Gut–Kidney Axis in Health and Disease
Stavropoulou, E., Kantartzi, K. M., Tsigalou, C., Konstantinidis, T. G., Romanidou, G. V., Voidarou, C. C., & Bezirtzoglou, E. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2020.620102 · Cited by 142
“Unexpectedly, a negative correlation between ratios of Bacteroidetes to Firmicutes and body mass index (BMI) was found (114, 123) (Table 1) as it seems that obesity and diabetes are associated with distinct species of the gut microbiota.”
BackgroundInfluential
Metadata
- Authors
- Larsen, N., Vogensen, F. K., van den Berg, F. W. J., Nielsen, D. S., Andreasen, A. S., Pedersen, B. K., Al-Soud, W. A., Sørensen, S. J., Hansen, L. H., & Jakobsen, M.
- Affiliations
- University of Copenhagen (DK)
- Rigshospitalet (DK)
- Corresponding author
- Larsen, Nadja
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-02-05
- Volume
- 5
- Issue
- 2
- Pages
- e9085
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2816710
- OpenAlex
- W2135989088
- Cited by
- 2,952
- References
- 38
- Citations by year
- 2026: 90 · 2025: 168 · 2024: 217 · 2023: 199 · 2022: 296 · 2021: 331 · 2020: 294 · 2019: 264 · 2018: 191 · 2017: 158 · 2016: 174 · 2015: 150 · 2014: 134 · 2013: 115 · 2012: 83
- FWCI
- 36.90
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Ministeriet for Fø devarer, Landbrug og Fiskeri
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- type 2 diabetes, gut microbiota, Firmicutes, Bacteroidetes, Betaproteobacteria, plasma glucose, glucose tolerance, obesity, metabolic disorders, 16S rRNA gene
- MeSH terms
- Adult, Aged, Bacteria, Diabetes Mellitus, Type 2, DNA, Bacterial, Feces, Humans, Intestines, Male, Middle Aged, RNA, Ribosomal, 16S, Colony Count, Microbial, Body Mass Index, Sequence Analysis, DNA
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.